The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients.Published in:Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1516, doi. 10.3390/ph15121516By:Elhini, Sahar H.;Wahsh, Engy A.;Elberry, Ahmed A.;El Ameen, Nadia F.;Abdelfadil Saedii, Ahmed;Refaie, Shereen Mahmoud;Elsayed, Asmaa A.;Rabea, Hoda M.Publication type:Article